Group 1 - The core business of the company is the manufacturing of medical devices and consumables in the respiratory health field, including various types of sleep breathing machines and monitoring devices [2] - As of March 31, 2025, the company had 9,118 shareholders, an increase of 1,481 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] - The company's latest quarterly report for Q1 2025 shows a revenue of 265 million yuan, a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, a year-on-year increase of 44.11%, with a gross profit margin of 49.57% [2] Group 2 - The company's current rolling price-to-earnings (PE) ratio is 48.82, while the industry average PE ratio is 57.48, and the industry median is 40.95, placing the company at the 85th position in the industry ranking [1][3] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents [2]
瑞迈特收盘下跌1.15%，滚动市盈率48.82倍，总市值86.60亿元